Evidence map›Paper›PMID 25274828›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Pro-brain-derived neurotrophic factor inhibits GABAergic neurotransmission by activating endocytosis and repression of GABAA receptors.

Baptiste Riffault, Igor Medina, Camille Dumon, Carine Thalman, Nadine Ferrand, Perrine Friedel, Jean-Luc Gaiarsa, Christophe Porcher

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The functional and molecular roles of p75 neurotrophin receptor (p75Journal of central nervous system disease · 2024
    Review
  6. BDNF-TrkB/proBDNF-p75Scientific reports · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Regulation of GABAMembranes · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. A NeurotoxicFrontiers in molecular neuroscience · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Baptiste RiffaultAix-Marseille Université, Institut National de la Santé et de la Recherche Médicale Unité 901, and Institut de Neurobiologie de la Méditerranée, Parc Scientifique de Luminy, 13273 Marseille, France.
Igor MedinaAix-Marseille Université, Institut National de la Santé et de la Recherche Médicale Unité 901, and Institut de Neurobiologie de la Méditerranée, Parc Scientifique de Luminy, 13273 Marseille, France.
Camille DumonAix-Marseille Université, Institut National de la Santé et de la Recherche Médicale Unité 901, and Institut de Neurobiologie de la Méditerranée, Parc Scientifique de Luminy, 13273 Marseille, France.ORCID http://orcid.org/0000-0002-1625-3091
Carine ThalmanAix-Marseille Université, Institut National de la Santé et de la Recherche Médicale Unité 901, and Institut de Neurobiologie de la Méditerranée, Parc Scientifique de Luminy, 13273 Marseille, France.
Nadine FerrandAix-Marseille Université, Institut National de la Santé et de la Recherche Médicale Unité 901, and Institut de Neurobiologie de la Méditerranée, Parc Scientifique de Luminy, 13273 Marseille, France.
Perrine FriedelAix-Marseille Université, Institut National de la Santé et de la Recherche Médicale Unité 901, and Institut de Neurobiologie de la Méditerranée, Parc Scientifique de Luminy, 13273 Marseille, France.
Jean-Luc GaiarsaAix-Marseille Université, Institut National de la Santé et de la Recherche Médicale Unité 901, and Institut de Neurobiologie de la Méditerranée, Parc Scientifique de Luminy, 13273 Marseille, France.
Christophe PorcherAix-Marseille Université, Institut National de la Santé et de la Recherche Médicale Unité 901, and Institut de Neurobiologie de la Méditerranée, Parc Scientifique de Luminy, 13273 Marseille, France Christophe.porcher@inserm.fr.ORCID http://orcid.org/0000-0002-6026-6367
Aix-Marseille Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GABA is the canonical inhibitory neurotransmitter in the CNS. This inhibitory action is largely mediated by GABA type A receptors (GABAARs). Among the many factors controlling GABAergic transmission, brain-derived neurotrophic factor (BDNF) appears to play a major role in regulating synaptic inhibition. Recent findings have demonstrated that BDNF can be released as a precursor (proBDNF). Although the role of mature BDNF on GABAergic synaptogenesis and maintenance has been well studied, an important question still unanswered is whether secreted proBDNF might affect GABAergic neurotransmission. Here, we have used 14 d in vitro primary culture of hippocampal neurons and ex vivo preparations from rats to study the function of proBDNF in regulation of GABAAR trafficking and activity. We demonstrate that proBDNF impairs GABAergic transmission by the activation of two distinct pathways: (1) a RhoA-Rock-PTEN pathway that decreases the phosphorylation levels of GABAAR, thus affecting receptor function and triggering endocytosis and degradation of internalized receptors, and (2) a JAK-STAT-ICER pathway leading to the repression of GABAARs synthesis. These effects lead to the diminution of GABAergic synapses and are correlated with a decrease in GABAergic synaptic currents. These results revealed new functions for proBDNF-p75 neurotrophin receptor signaling pathway in the control of the efficacy of GABAergic synaptic activity by regulating the trafficking and synthesis of GABAARs at inhibitory synapses.

Indexed as

AnimalsAnimals, NewbornBrain-Derived Neurotrophic FactorEndocytosisEnzyme InhibitorsExcitatory Amino Acid Antagonistsgamma-Aminobutyric AcidGene Expression RegulationHippocampusInhibitory Postsynaptic PotentialsNerve Tissue ProteinsNeuronal PlasticityNeuronsQuinoxalinesRatsRats, Wistar2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline2-amino-5-phosphopentanoic acidBrain-Derived Neurotrophic FactorEnzyme InhibitorsExcitatory Amino Acid Antagonistsgamma-Aminobutyric AcidNerve Tissue ProteinsQuinoxalinesReceptors, GABASodium Channel BlockersTetrodotoxinValineBDNFGABAA receptorsintracellular traffickingsynaptic plasticity

Identifiers

PMID25274828
PMCPMC6608319
OpenAlexW1982504898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.